Spas Bet on Skin Science and Local Beauty, Even as Some Travelers Tune Out the Data

Skyscanner data cited this week shows 32% of travelers now actively seek local beauty experiences, and hotel spas are moving to meet it. Four Seasons Prague's AVA Spa has added treatments built around Czech brand Mcely Bouquet; Portofino properties are steering guests toward medspa referral partnerships; Montage has rolled out region-specific Elements of Wellness treatments across its portfolio. For advisors, this is a concrete upsell: rather than generic spa credits, clients can now book a destination-specific treatment tied to a recognizable regional or artisanal brand. It's a differentiator worth flagging on quote sheets for spa-focused itineraries, and a reason to ask any property under consideration what local or regional product lines it actually stocks versus a standard international spa-menu template.

• Four Seasons Prague (AVA Spa): treatments built around Czech brand Mcely Bouquet
• Portofino properties: medspa referral tie-ups
• Montage: regional Elements of Wellness treatments portfolio-wide

Fresh venture capital is flowing into skin-longevity science: Beiersdorf has launched a fund exceeding $100M and Rapalogix has raised $20M around TORC1-pathway skin longevity technology, according to Global Wellness Institute trend coverage. Expect that capital to filter into treatment menus at longevity-oriented properties — cellular-health diagnostics and regenerative facials positioned alongside traditional spa services at brands like SHA Wellness, Clinique La Prairie, and Lanserhof. The commercial upside for advisors is real, but so is the risk of overclaiming: as the science commercializes faster than regulation or independent validation, some properties will market unsubstantiated 'longevity' language. Before positioning a premium longevity-skin package to a client, it's worth asking the property directly what clinical backing sits behind the treatment, not just the marketing copy.

A counter-trend is building against the wearables-and-metrics culture that has defined much of wellness travel: Global Wellness Institute coverage points to a rising segment of travelers who say they'd rather trust how their body feels than what a ring or watch tells them. That's a usable marketing angle for retreat operators and longevity programs that have leaned analog rather than tech-forward — no continuous glucose monitors, no sleep-score dashboards, just structured downtime and practitioner-led assessment. For advisors, it's a way to differentiate a client pitch: not every wellness traveler wants a data readout at checkout, and a retreat that explicitly unplugs guests from tracking can be positioned as the premium, higher-touch option rather than the low-tech one.

eMed, with Tom Brady as its wellness ambassador, is pushing for broader employer coverage of GLP-1 weight-loss drugs — notable because roughly 60% of Americans get health benefits through an employer, per eMed's CEO. As that access expands, advisors booking medical-wellness and corporate retreat programs should expect a growing share of clients already on GLP-1s, with itinerary needs that differ from a standard spa week: muscle-preservation programming, skin-tightening treatments, and nutrition support tailored to appetite suppression rather than general wellness reset. Worth flagging proactively with corporate wellness-retreat clients and longevity-program operators, since screening intake forms that don't currently ask about GLP-1 use may need updating to route guests to the right program track.